Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 67 results for "international society of pharmacovigi..."

Yakasai tasks pharmacy students in Africa on evidence-based cl...

PSN President, Ahmed I. Yakasai President of the Pharmaceutical Society of Nigeria (PSN), Ahmed Yakasai, has challenged pharmacy students in Africa on evidencebased pharmacy, meeting patients needs, chronic patients care especially in Human ... The Guardian Nigeria, 5 days ago

Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis (gMG)

Alexion Pharmaceuticals today announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris®) in patients with refractory generalized myasthenia gravis (gMG). Alexion Pharmaceuticals, Inc. ( NASDAQ: ALXN ) ...
 Minyanville3 weeks ago Alexion Reports First Quarter 2016 Results  Minyanville2 months ago
[x]  

UBIC Announces Corporate Name Changes for UBIC, Inc. and Related Subsidiaries

UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) ("UBIC" or "the Company"), a leading provider of international litigation support and big data analysis services, today announced that pursuant to its Board of Directors Meeting on May 26, 2016, a resolution was ...
 International Business Times1 month ago
[x]  

Ways to reduce the burden of disease. Every community pharmacist has a part!

When a baby is born in your country, how many years in full health can he or she be expected to live? Or, to look at it in another way, how much time can he or she expect to spend in poor health? This is the basis of HALE (health adjusted life ...
 Graphic Ghana1 month ago

American College of Rheumatology Release: Rheumatology Providers, FDA Leaders Discuss Biosimilar Policy Challenges And Opportunities At National Policy Briefing

(GLOBE NEWSWIRE) -- Experts from the American College of Rheumatology (ACR), Food and Drug Administration (FDA), and other leading national healthcare groups spoke about the emerging biosimilars market, including key policy and regulatory questions ...
 BioSpace1 week ago Rheumatology Providers, FDA Leaders Discuss Biosimilar Policy Challenges and Opportunities at National Policy Briefing  Benzinga.com1 week ago
[x]  
Africa News Network7

DA health concerns are about electioneering: FS Health

Head of Health in the Free State. Dr. David Motau. Picture:Supplied. Free State department of health has assured the public that its budget and medicine stock are in good standing as department has adequately budgeted for this financial year. ...
 Africa News Network71 week ago Tunisian health sector to undergo overhaul  Oxford Business Group2 months ago

EMEA Healthcare Industry Group Newsletter - June 2016

EU reaches agreement on Medical Devices and In Vitro Diagnostics Regulations It has been quiet since the trilogue discussions first started but on 25 May 2016 it was announced that the Commission, Council and Parliament reached a political ...
 Lexology1 week ago

HAI Provides EU Member States with Recommendations that Promote Therapeutically Advantangeous and Affordable Medicines

Home / Publications / HAI Provides EU Member States with Recommendations that Promote Therapeutically Advantangeous and Affordable Medicines (HAI letter to European Union Health Attachés and Ministersprior to their meetings to discuss Council ...
 Health Action International3 weeks ago

New data reaffirm positive benefit/risk balance of Xarelto® in AF patients

Bayer announced results from a new real-world study, REVISIT-US. In REVISIT-US reduced rates of ischemic stroke accompanied by reduced rates of intracranial haemorrhage (ICH) were seen with Xarelto ® (rivaroxaban) versus warfarin in patients with ...
 The Specialist Forum4 weeks ago Positive Benefit-Risk Balance of rivaroxaban in AF  Medical Chronicle.co.za1 month ago

Clinical and regulatory issues for bi...

Biosimilars are follow-on biologicals that are approved through an abbreviated regulatory pathway. Unlike small molecule generics, the size, complexity and manufacturing processes are such that it is virtually impossible to create identical copies ...
 GaBi Online1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - international society of pharmacovigilance
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less